Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...

Katelyn is a writer with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...

Leeron is a New York-based writer who specializes in covering technology for small and mid-sized businesses. Her work has been featured in publications including Bankrate, Quartz, the Village Voice, ...

First, you spend a small fortune just to buy the unit and install it. Then comes the real nightmare: maintenance and repairs that are outrageously expensive, to the point where it feels like a scam.

Bad Bunny is set to take the stage at the 2026 Super Bowl halftime show, following on from the iconic Kendrick Lamar performance. With him winning at the 2026 Grammys for his hit-album 'Debí Tirar Más ...

Analysts are cautiously optimistic about an IPO rebound for biopharma. BioSpace is keeping track of companies that seek to trade on the public markets this year. 2025 was a slow year for IPOs, with ...